Report cover image

Alcoholic Hepatitis Treatment Market

Publisher Future Market Insights
Published May 10, 2023
Length 365 Pages
SKU # FMARI19463929

Description

Alcoholic Hepatitis Treatment Market


Alcoholic Hepatitis Treatment Market: Global Industry Analysis 2012-2022 and Opportunity Assessment 2023-2033

A recent market study published by FMI on Alcoholic Hepatitis Treatment offers a global industry analysis for 2012-2022 and opportunity assessment for 2023-2033. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision.

Market Segmentation

By Treatment:
  • Drug Treatment
  • Acamprosate
  • Naltrexone
  • Pentoxifylline
  • Infliximab
  • Corticosteroids
  • Benzodiazepines
  • Nutritional Supplements
  • Others
  • Stem Cell Therapy
By Route of Administration:
  • Oral
  • Injectable
By Distribution Channel:
  • Institutional Sales
  • Hospitals
  • Stem Cell Centers
  • Specialized Clinics
  • Cancer Research Institutes
  • Retail Sales
  • Retail Pharmacies
  • E- Commerce/Mail Order Pharmacies
By Region:
  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)
Report Chapters

Executive Summary

The executive summary of the Alcoholic Hepatitis Treatment Market includes the global market outlook, demand side trends, supply side trends and also include FMI analysis and recommendations of Vehicle Radar Test System.

Chapter 01 - Market Overview

Readers can find the detailed segmentation and definition of the Alcoholic Hepatitis Treatment Market in this chapter, which will help to understand basic information about Vehicle Radar Test System. This section also highlights the market scope, taxonomy and limitations which help the reader understand the market coverage of Alcoholic Hepatitis Treatment Market report.

Chapter 02 - Market Background

This chapter includes detailed analysis of the By Treatment processing methods overview, consumer buying patterns & tendencies and policy developments and regulatory scenario. It also includes in depth analysis of macro-economic factors and covers topics like global GDP growth outlook, global industry value added, personal consumption, expenditures, modern trade penetration and consumer price indices. The chapter also covers forecast factors - relevance & impact, value chain analysis and market dynamics (drivers, restraints and opportunities) to better understand the market.

Chapter 03 - Global Alcoholic Hepatitis Treatment Market Demand Analysis 2012-2022 and Forecast, 2023-2033

The chapter include historical market value (US$ 2.6 Billion) analysis (2012-2022) and current and future market value (US$ 2.8 Billion) and volume (6.5%) projections (2023-2033). The projections are based on the Y-O-Y growth trend analysis and absolute $ opportunity analysis country of operation.

Chapter 04 - Global Alcoholic Hepatitis Treatment Market - Pricing Analysis

Based on By Treatment, the pricing analysis chapter include Regional pricing analysis (USD/MT), global average pricing analysis benchmark, and key factors impacting the pricing.

Chapter 05 - Global Alcoholic Hepatitis Treatment Market Analysis 2012-2022 and Forecast 2023-2033, By Treatment

Based on By Treatment, Alcoholic Hepatitis Treatment Market is segmented into Drug Treatment (Acamprosate, Naltrexone, Pentoxifylline, Infliximab, Corticosteroids, Benzodiazepines, Nutritional Supplements, Others), Stem Cell Therapy. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Treatment.

Chapter 06 - Global Alcoholic Hepatitis Treatment Market Analysis 2012-2022 and Forecast 2023-2033, By Route of Administration

Based on By Route of Administration, Alcoholic Hepatitis Treatment Market is segmented into Oral, Injectable. This section also offers market attractiveness analysis based on By Route of Administration. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Route of Administration.

Chapter 07 - Global Alcoholic Hepatitis Treatment Market Analysis 2012-2022 and Forecast 2023-2033, By Distribution Channel

Based on By Distribution Channel, Alcoholic Hepatitis Treatment Market is segmented into Institutional Sales (Hospitals, Stem Cell Centers, Specialized Clinics, Cancer Research Institutes), Retail Sales (Retail Pharmacies, E- Commerce/Mail Order Pharmacies). This section also offers market attractiveness analysis based on By Distribution Channel. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Distribution Channel.

Chapter 08 - Alcoholic Hepatitis Treatment Market Analysis 2012-2022 and Forecast 2023-2033, By Region

Based on By Region, Alcoholic Hepatitis Treatment Market is segmented into North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East and Africa (MEA). This section also offers market attractiveness analysis based on By Region. Readers can also find value forecast and Y-o-Y growth comparison for all above mentioned By Region.

Chapter 09 - North America Alcoholic Hepatitis Treatment Market Analysis 2012-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of the Vehicle Radar Test System in the North American region, along with a country-wise assessment that includes the US and Canada. Readers can also find regional trends, regulations, and market growth based on different segment and countries in the North America region.

Chapter 10 - Latin America Alcoholic Hepatitis Treatment Market Analysis 2012-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the Latin America region, along with a country-wise assessment that includes the Brazil, Mexico, Chile, Argentina, Peru and Rest of Latin America. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Alcoholic Hepatitis Treatment Market in the Latin America region.

Chapter 11 - Europe Alcoholic Hepatitis Treatment Market Analysis 2012-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the European region, along with a country-wise assessment that includes the Germany, Italy, France, U.K., Spain, Russia, Nordic, Benelux and Rest of Europe. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Alcoholic Hepatitis Treatment Market in the regional market.

Chapter 12 - East Asia Alcoholic Hepatitis Treatment Market Analysis 2012-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the East Asia region, along with a country-wise assessment that includes the China, Japan, and South Korea. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Alcoholic Hepatitis Treatment Market in the regional market.

Chapter 13 - South Asia Alcoholic Hepatitis Treatment Market Analysis 2012-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the South Asia region, along with a country-wise assessment that includes the India, Indonesia, Malaysia, Thailand, and Rest of South Asia. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Alcoholic Hepatitis Treatment Market in the regional market.

Chapter 14 - Middle East and Africa Alcoholic Hepatitis Treatment Market Analysis 2012-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the MEA region, along with a country-wise assessment that includes the GCC Countries, South Africa, North Africa, Turkey and Rest of MEA. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Alcoholic Hepatitis Treatment Market in the regional market.

Chapter 15 - Key Countries Alcoholic Hepatitis Treatment Market Analysis 2012-2022 and Forecast 2023-2033

This chapter offers insights into how the Alcoholic Hepatitis Treatment Market is expected to grow in major countries globally.

Chapter 16 - Market Structure Analysis- Global Assessment

This chapter includes company dashboard, industry structure analysis by tier of companies, 2022E, company share analysis of top players, 2022E, and competition benchmarking- matrix.

Chapter 17 - Competition Deep Dive (Tentative List)

This chapter includes company overview, By Treatment portfolio of companies, profitability by market segments, sales footprint, SWOT analysis and strategy overview of the companies being studied in the report. Some of the market players featured in the report are F. Hoffmann-La Roche Ltd (Genentech, Inc), Teva Pharmaceuticals, Pfizer, Alkermes, Inc, Viatris Inc, Merck KGaA, Sun Pharmaceutical Industries Ltd, Hikma Pharmaceuticals PLC, H. Lundbeck A/S, Mallinckrodt, Glenmark Pharmaceuticals U.S. Inc, Torrent Pharmaceuticals Ltd, Wellona Pharma.

Chapter 18 - Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Vehicle Radar Test System report.

Chapter 19 - Research Methodology

This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on Alcoholic Hepatitis Treatment Market.

Table of Contents

365 Pages
1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand Side Trends
    1.3. Supply Side Trends
    1.4. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
    2.3. Inclusions and Exclusions
3. Key Market Trends
    3.1. Key Trends Impacting the Market
4. Value-Added Insights
    4.1. Product Adoption / Usage Analysis
    4.2. Disease spectrum
    4.3. Algorithm For The Evaluation And Management of Patients with Alcoholic Liver Disease
    4.4. Therapeutic Algorithm Of Alcoholic Liver Disease
    4.5. Regulatory Scenario
    4.6. PESTLE Analysis
    4.7. Porter’s Analysis
    4.8. Key Promotional Strategies, by Key Manufacturers
5. Market Background
    5.1. Macro-Economic Factors
        5.1.1. Global GDP Growth Outlook
        5.1.2. Global Healthcare Expenditure Outlook
    5.2. Forecast Factors - Relevance & Impact
        5.2.1. Top Companies Historical Growth
        5.2.2. Increasing Prevalence of Chronic Liver Diseases
        5.2.3. Treatment Seeking Rate
        5.2.4. Key Strategic Developments
        5.2.5. Increasing Investment in R&D Activities
        5.2.6. Cost of Drugs
        5.2.7. Regulatory Dynamics
    5.3. Market Dynamics
        5.3.1. Drivers
        5.3.2. Restraints
        5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
    6.1. COVID-19 and Impact Analysis
        6.1.1. Revenue By Treatment
        6.1.2. Revenue By Route of Administration
        6.1.3. Revenue By Distribution Channel
        6.1.4. Revenue By Country
    6.2. 2022 Market Scenario
7. Global Market Demand Value or Size (US$ Million) Analysis 2012 to 2022 and Forecast, 2023 to 2033
    7.1. Historical Market Value (US$ Million) Trend Analysis, 2013 to 2023
    7.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
        7.2.1. Y-o-Y Growth Trend Analysis
        7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, by Treatment
    8.1. Introduction / Key Findings
    8.2. Historical Market Size (US$ Million) Analysis By Treatment, 2012 to 2022
    8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Treatment, 2023 to 2033
        8.3.1. Drug Treatment
            8.3.1.1. Acamprosate
            8.3.1.2. Naltrexone
            8.3.1.3. Pentoxifylline
            8.3.1.4. Infliximab
            8.3.1.5. Corticosteroids
            8.3.1.6. Benzodiazepines
            8.3.1.7. Nutritional Supplements
            8.3.1.8. Others
        8.3.2. Stem Cell Therapy
    8.4. Market Attractiveness Analysis By Treatment
9. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, by Route of Administration
    9.1. Introduction / Key Findings
    9.2. Historical Market Size (US$ Million), By Route of Administration, 2012 to 2022
    9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Route of Administration, 2023 to 2033
        9.3.1. Oral
        9.3.2. Injectable
    9.4. Market Attractiveness Analysis By Route of Administration
10. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, by Distribution Channel
    10.1. Introduction / Key Findings
    10.2. Historical Market Size (US$ Million), By Distribution Channel, 2012 to 2022
    10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Distribution Channel, 2023 to 2033
        10.3.1. Institutional Sales
            10.3.1.1. Hospitals
            10.3.1.2. Stem Cell Centers
            10.3.1.3. Specialized Clinics
            10.3.1.4. Cancer Research Institutes
        10.3.2. Retail Sales
            10.3.2.1. Retail Pharmacies
            10.3.2.2. E-Commerce/Mail Order Pharmacies
    10.4. Market Attractiveness Analysis By Distribution Channel
11. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, by Region
    11.1. Introduction
    11.2. Historical Market Size (US$ Million) Analysis By Region, 2012 to 2022
    11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2023 to 2033
        11.3.1. North America
        11.3.2. Latin America
        11.3.3. Europe
        11.3.4. East Asia
        11.3.5. South Asia
        11.3.6. Oceania
        11.3.7. Middle East and Africa (MEA)
    11.4. Market Attractiveness Analysis By Region
12. North America Market Analysis 2012 to 2022 and Forecast 2023 to 2033
    12.1. Introduction
    12.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2012 to 2022
    12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033
        12.3.1. By Country
            12.3.1.1. USA
            12.3.1.2. Canada
        12.3.2. By Treatment
        12.3.3. By Route of Administration
        12.3.4. By Distribution Channel
    12.4. Market Attractiveness Analysis
        12.4.1. By Country
        12.4.2. By Treatment
        12.4.3. By Route of Administration
        12.4.4. By Distribution Channel
    12.5. Market Trends
    12.6. Key Market Participants - Intensity Mapping
    12.7. Drivers and Restraints - Impact Analysis
    12.8. Country-Level Analysis & Forecast
        12.8.1. USA Market Analysis
            12.8.1.1. Introduction
            12.8.1.2. Market Analysis and Forecast by Market Taxonomy
                12.8.1.2.1. By Treatment
                12.8.1.2.2. By Route of Administration
                12.8.1.2.3. By Distribution Channel
        12.8.2. Canada Market Analysis
            12.8.2.1. Introduction
            12.8.2.2. Market Analysis and Forecast by Market Taxonomy
                12.8.2.2.1. By Treatment
                12.8.2.2.2. By Route of Administration
                12.8.2.2.3. By Distribution Channel
13. Latin America Market Analysis 2012 to 2022 and Forecast 2023 to 2033
    13.1. Introduction
    13.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2012 to 2022
    13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033
        13.3.1. By Country
            13.3.1.1. Mexico
            13.3.1.2. Brazil
            13.3.1.3. Argentina
            13.3.1.4. Rest of Latin America
        13.3.2. By Treatment
        13.3.3. By Route of Administration
        13.3.4. By Distribution Channel
    13.4. Market Attractiveness Analysis
        13.4.1. By Country
        13.4.2. By Treatment
        13.4.3. By Route of Administration
        13.4.4. By Distribution Channel
    13.5. Market Trends
    13.6. Key Market Participants - Intensity Mapping
    13.7. Drivers and Restraints - Impact Analysis
    13.8. Country-Level Analysis & Forecast
        13.8.1. Mexico Market Analysis
            13.8.1.1. Introduction
            13.8.1.2. Market Analysis and Forecast by Market Taxonomy
                13.8.1.2.1. By Treatment
                13.8.1.2.2. By Route of Administration
                13.8.1.2.3. By Distribution Channel
        13.8.2. Brazil Market Analysis
            13.8.2.1. Introduction
            13.8.2.2. Market Analysis and Forecast by Market Taxonomy
                13.8.2.2.1. By Treatment
                13.8.2.2.2. By Route of Administration
                13.8.2.2.3. By Distribution Channel
        13.8.3. Argentina Market Analysis
            13.8.3.1. Introduction
            13.8.3.2. Market Analysis and Forecast by Market Taxonomy
                13.8.3.2.1. By Treatment
                13.8.3.2.2. By Route of Administration
                13.8.3.2.3. By Distribution Channel
14. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033
    14.1. Introduction
    14.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2012 to 2022
    14.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033
        14.3.1. By Country
            14.3.1.1. Germany
            14.3.1.2. Italy
            14.3.1.3. France
            14.3.1.4. United Kingdom
            14.3.1.5. Spain
            14.3.1.6. BENELUX
            14.3.1.7. Russia
            14.3.1.8. Rest of Europe
        14.3.2. By Treatment
        14.3.3. By Route of Administration
        14.3.4. By Distribution Channel
    14.4. Market Attractiveness Analysis
        14.4.1. By Country
        14.4.2. By Treatment
        14.4.3. By Route of Administration
        14.4.4. By Distribution Channel
    14.5. Market Trends
    14.6. Key Market Participants - Intensity Mapping
    14.7. Drivers and Restraints - Impact Analysis
    14.8. Country-Level Analysis & Forecast
        14.8.1. Germany Market Analysis
            14.8.1.1. Introduction
            14.8.1.2. Market Analysis and Forecast by Market Taxonomy
                14.8.1.2.1. By Treatment
                14.8.1.2.2. By Route of Administration
                14.8.1.2.3. By Distribution Channel
        14.8.2. Italy Market Analysis
            14.8.2.1. Introduction
            14.8.2.2. Market Analysis and Forecast by Market Taxonomy
                14.8.2.2.1. By Treatment
                14.8.2.2.2. By Route of Administration
                14.8.2.2.3. By Distribution Channel
        14.8.3. France Market Analysis
            14.8.3.1. Introduction
            14.8.3.2. Market Analysis and Forecast by Market Taxonomy
                14.8.3.2.1. By Treatment
                14.8.3.2.2. By Route of Administration
                14.8.3.2.3. By Distribution Channel
        14.8.4. United Kingdom Market Analysis
            14.8.4.1. Introduction
            14.8.4.2. Market Analysis and Forecast by Market Taxonomy
                14.8.4.2.1. By Treatment
                14.8.4.2.2. By Route of Administration
                14.8.4.2.3. By Distribution Channel
        14.8.5. Spain Market Analysis
            14.8.5.1. Introduction
            14.8.5.2. Market Analysis and Forecast by Market Taxonomy
                14.8.5.2.1. By Treatment
                14.8.5.2.2. By Route of Administration
                14.8.5.2.3. By Distribution Channel
        14.8.6. BENELUX Market Analysis
            14.8.6.1. Introduction
            14.8.6.2. Market Analysis and Forecast by Market Taxonomy
                14.8.6.2.1. By Treatment
                14.8.6.2.2. By Route of Administration
                14.8.6.2.3. By Distribution Channel
        14.8.7. Russia Market Analysis
            14.8.7.1. Introduction
            14.8.7.2. Market Analysis and Forecast by Market Taxonomy
                14.8.7.2.1. By Treatment
                14.8.7.2.2. By Route of Administration
                14.8.7.2.3. By Distribution Channel
15. South Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033
    15.1. Introduction
    15.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2012 to 2022
    15.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033
        15.3.1. By Country
            15.3.1.1. India
            15.3.1.2. Indonesia
            15.3.1.3. Malaysia
            15.3.1.4. Thailand
            15.3.1.5. Rest of South Asia
        15.3.2. By Treatment
        15.3.3. By Route of Administration
        15.3.4. By Distribution Channel
    15.4. Market Attractiveness Analysis
        15.4.1. By Country
        15.4.2. By Treatment
        15.4.3. By Route of Administration
        15.4.4. By Distribution Channel
    15.5. Market Trends
    15.6. Key Market Participants - Intensity Mapping
    15.7. Drivers and Restraints - Impact Analysis
    15.8. Country-Level Analysis & Forecast
        15.8.1. India Market Analysis
            15.8.1.1. Introduction
            15.8.1.2. Market Analysis and Forecast by Market Taxonomy
                15.8.1.2.1. By Treatment
                15.8.1.2.2. By Route of Administration
                15.8.1.2.3. By Distribution Channel
        15.8.2. Indonesia Market Analysis
            15.8.2.1. Introduction
            15.8.2.2. Market Analysis and Forecast by Market Taxonomy
                15.8.2.2.1. By Treatment
                15.8.2.2.2. By Route of Administration
                15.8.2.2.3. By Distribution Channel
        15.8.3. Malaysia Market Analysis
            15.8.3.1. Introduction
            15.8.3.2. Market Analysis and Forecast by Market Taxonomy
                15.8.3.2.1. By Treatment
                15.8.3.2.2. By Route of Administration
                15.8.3.2.3. By Distribution Channel
        15.8.4. Thailand Market Analysis
            15.8.4.1. Introduction
            15.8.4.2. Market Analysis and Forecast by Market Taxonomy
                15.8.4.2.1. By Treatment
                15.8.4.2.2. By Route of Administration
                15.8.4.2.3. By Distribution Channel
16. East Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033
    16.1. Introduction
    16.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2012 to 2022
    16.3. Current and Future Market Size (US$ Million) Analysis Forecast By Market Taxonomy, 2023 to 2033
        16.3.1. By Country
            16.3.1.1. China
            16.3.1.2. Japan
            16.3.1.3. South Korea
        16.3.2. By Treatment
        16.3.3. By Route of Administration
        16.3.4. By Distribution Channel
    16.4. Market Attractiveness Analysis
        16.4.1. By Country
        16.4.2. By Treatment
        16.4.3. By Route of Administration
        16.4.4. By Distribution Channel
    16.5. Market Trends
    16.6. Key Market Participants - Intensity Mapping
    16.7. Drivers and Restraints - Impact Analysis
    16.8. Country-Level Analysis & Forecast
        16.8.1. China Market Analysis
            16.8.1.1. Introduction
            16.8.1.2. Market Analysis and Forecast by Market Taxonomy
                16.8.1.2.1. By Treatment
                16.8.1.2.2. By Route of Administration
                16.8.1.2.3. By Distribution Channel
        16.8.2. Japan Market Analysis
            16.8.2.1. Introduction
            16.8.2.2. Market Analysis and Forecast by Market Taxonomy
                16.8.2.2.1. By Treatment
                16.8.2.2.2. By Route of Administration
                16.8.2.2.3. By Distribution Channel
        16.8.3. South Korea Market Analysis
            16.8.3.1. Introduction
            16.8.3.2. Market Analysis and Forecast by Market Taxonomy
                16.8.3.2.1. By Treatment
                16.8.3.2.2. By Route of Administration
                16.8.3.2.3. By Distribution Channel
17. Oceania Market 2012 to 2022 and Forecast 2023 to 2033
    17.1. Introduction
    17.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2012 to 2022
    17.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033
        17.3.1. By Country
            17.3.1.1. Australia
            17.3.1.2. New Zealand
        17.3.2. By Treatment
        17.3.3. By Route of Administration
        17.3.4. By Distribution Channel
    17.4. Market Attractiveness Analysis
        17.4.1. By Country
        17.4.2. By Treatment
        17.4.3. By Route of Administration
        17.4.4. By Distribution Channel
    17.5. Market Trends
    17.6. Key Market Participants - Intensity Mapping
    17.7. Drivers and Restraints - Impact Analysis
    17.8. Country-Level Analysis & Forecast
        17.8.1. Australia Market Analysis
            17.8.1.1. Introduction
            17.8.1.2. Market Analysis and Forecast by Market Taxonomy
                17.8.1.2.1. By Treatment
                17.8.1.2.2. By Route of Administration
                17.8.1.2.3. By Distribution Channel
        17.8.2. New Zealand Market Analysis
            17.8.2.1. Introduction
            17.8.2.2. Market Analysis and Forecast by Market Taxonomy
                17.8.2.2.1. By Treatment
                17.8.2.2.2. By Route of Administration
                17.8.2.2.3. By Distribution Channel
18. Middle East and Africa (MEA) Market Analysis 2012 to 2022 and Forecast 2023 to 2033
    18.1. Introduction
    18.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2012 to 2022
    18.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033
        18.3.1. By Country
            18.3.1.1. GCC Countries
            18.3.1.2. Türkiye
            18.3.1.3. South Africa
            18.3.1.4. North Africa
            18.3.1.5. Rest of Middle East and Africa
        18.3.2. By Treatment
        18.3.3. By Route of Administration
        18.3.4. By Distribution Channel
    18.4. Market Attractiveness Analysis
        18.4.1. By Country
        18.4.2. By Treatment
        18.4.3. By Route of Administration
        18.4.4. By Distribution Channel
    18.5. Market Trends
    18.6. Key Market Participants - Intensity Mapping
    18.7. Drivers and Restraints - Impact Analysis
    18.8. Country-Level Analysis & Forecast
        18.8.1. GCC Countries Market Analysis
            18.8.1.1. Introduction
            18.8.1.2. Market Analysis and Forecast by Market Taxonomy
                18.8.1.2.1. By Treatment
                18.8.1.2.2. By Route of Administration
                18.8.1.2.3. By Distribution Channel
        18.8.2. Türkiye Market Analysis
            18.8.2.1. Introduction
            18.8.2.2. Market Analysis and Forecast by Market Taxonomy
                18.8.2.2.1. By Treatment
                18.8.2.2.2. By Route of Administration
                18.8.2.2.3. By Distribution Channel
        18.8.3. South Africa Market Analysis
            18.8.3.1. Introduction
            18.8.3.2. Market Analysis and Forecast by Market Taxonomy
                18.8.3.2.1. By Treatment
                18.8.3.2.2. By Route of Administration
                18.8.3.2.3. By Distribution Channel
        18.8.4. North Africa Market Analysis
            18.8.4.1. Introduction
            18.8.4.2. Market Analysis and Forecast by Market Taxonomy
                18.8.4.2.1. By Treatment
                18.8.4.2.2. By Route of Administration
                18.8.4.2.3. By Distribution Channel
19. Market Structure Analysis
    19.1. Market Analysis by Tier of Companies
    19.2. Market Share Analysis of Top Players
    19.3. Market Presence Analysis
        19.3.1. Regional Footprint Analysis
        19.3.2. Channel Footprint Analysis
20. Competition Analysis
    20.1. Competition Dashboard
    20.2. Competition Benchmarking
    20.3. Key Development Analysis
    20.4. Branding and Promotional Strategies
    20.5. Competition Deep Dive
        20.5.1. F. Hoffmann-La Roche Ltd (Genentech, Inc)
            20.5.1.1. Overview
            20.5.1.2. Product Portfolio
            20.5.1.3. Key Financial
            20.5.1.4. Sales Footprint
            20.5.1.5. Key Developments
            20.5.1.6. SWOT Analysis
            20.5.1.7. Strategy Overview
                20.5.1.7.1. Marketing Strategies
                20.5.1.7.2. Channel Strategies
        20.5.2. Teva Pharmaceuticals
            20.5.2.1. Overview
            20.5.2.2. Product Portfolio
            20.5.2.3. Key Financial
            20.5.2.4. Sales Footprint
            20.5.2.5. Key Developments
            20.5.2.6. SWOT Analysis
            20.5.2.7. Strategy Overview
                20.5.2.7.1. Marketing Strategies
                20.5.2.7.2. Channel Strategies
        20.5.3. Pfizer
            20.5.3.1. Overview
            20.5.3.2. Product Portfolio
            20.5.3.3. Key Financial
            20.5.3.4. Sales Footprint
            20.5.3.5. Key Developments
            20.5.3.6. SWOT Analysis
            20.5.3.7. Strategy Overview
                20.5.3.7.1. Marketing Strategies
                20.5.3.7.2. Channel Strategies
        20.5.4. Alkermes, Inc
            20.5.4.1. Overview
            20.5.4.2. Product Portfolio
            20.5.4.3. Key Financial
            20.5.4.4. Sales Footprint
            20.5.4.5. Key Developments
            20.5.4.6. SWOT Analysis
            20.5.4.7. Strategy Overview
                20.5.4.7.1. Marketing Strategies
                20.5.4.7.2. Channel Strategies
        20.5.5. Viatris Inc
            20.5.5.1. Overview
            20.5.5.2. Product Portfolio
            20.5.5.3. Key Financial
            20.5.5.4. Sales Footprint
            20.5.5.5. Key Developments
            20.5.5.6. SWOT Analysis
            20.5.5.7. Strategy Overview
                20.5.5.7.1. Marketing Strategies
                20.5.5.7.2. Channel Strategies
        20.5.6. Merck KGaA
            20.5.6.1. Overview
            20.5.6.2. Product Portfolio
            20.5.6.3. Key Financial
            20.5.6.4. Sales Footprint
            20.5.6.5. Key Developments
            20.5.6.6. SWOT Analysis
            20.5.6.7. Strategy Overview
                20.5.6.7.1. Marketing Strategies
                20.5.6.7.2. Channel Strategies
        20.5.7. Sun Pharmaceutical Industries Ltd
            20.5.7.1. Overview
            20.5.7.2. Product Portfolio
            20.5.7.3. Key Financial
            20.5.7.4. Sales Footprint
            20.5.7.5. Key Developments
            20.5.7.6. SWOT Analysis
            20.5.7.7. Strategy Overview
                20.5.7.7.1. Marketing Strategies
                20.5.7.7.2. Channel Strategies
        20.5.8. Hikma Pharmaceuticals PLC
            20.5.8.1. Overview
            20.5.8.2. Product Portfolio
            20.5.8.3. Key Financial
            20.5.8.4. Sales Footprint
            20.5.8.5. Key Developments
            20.5.8.6. SWOT Analysis
            20.5.8.7. Strategy Overview
                20.5.8.7.1. Marketing Strategies
                20.5.8.7.2. Channel Strategies
        20.5.9. H. Lundbeck A/S
            20.5.9.1. Overview
            20.5.9.2. Product Portfolio
            20.5.9.3. Key Financial
            20.5.9.4. Sales Footprint
            20.5.9.5. Key Developments
            20.5.9.6. SWOT Analysis
            20.5.9.7. Strategy Overview
                20.5.9.7.1. Marketing Strategies
                20.5.9.7.2. Channel Strategies
        20.5.10. Mallinckrodt
            20.5.10.1. Overview
            20.5.10.2. Product Portfolio
            20.5.10.3. Key Financial
            20.5.10.4. Sales Footprint
            20.5.10.5. Key Developments
            20.5.10.6. SWOT Analysis
            20.5.10.7. Strategy Overview
                20.5.10.7.1. Marketing Strategies
                20.5.10.7.2. Channel Strategies
        20.5.11. Glenmark Pharmaceuticals USA Inc
            20.5.11.1. Overview
            20.5.11.2. Product Portfolio
            20.5.11.3. Key Financial
            20.5.11.4. Sales Footprint
            20.5.11.5. Key Developments
            20.5.11.6. SWOT Analysis
            20.5.11.7. Strategy Overview
                20.5.11.7.1. Marketing Strategies
                20.5.11.7.2. Channel Strategies
        20.5.12. Torrent Pharmaceuticals Ltd
            20.5.12.1. Overview
            20.5.12.2. Product Portfolio
            20.5.12.3. Key Financial
            20.5.12.4. Sales Footprint
            20.5.12.5. Key Developments
            20.5.12.6. SWOT Analysis
            20.5.12.7. Strategy Overview
                20.5.12.7.1. Marketing Strategies
                20.5.12.7.2. Channel Strategies
        20.5.13. Wellona Pharma
            20.5.13.1. Overview
            20.5.13.2. Product Portfolio
            20.5.13.3. Key Financial
            20.5.13.4. Sales Footprint
            20.5.13.5. Key Developments
            20.5.13.6. SWOT Analysis
            20.5.13.7. Strategy Overview
                20.5.13.7.1. Marketing Strategies
                20.5.13.7.2. Channel Strategies
21. Assumptions and Acronyms Used
22. Research Methodology

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us